IBBvsVHT

iShares Biotechnology ETF or Vanguard Health Care ETF, side by side from their own SEC filings. 17% of their stock holdings are the same at the same weight, across 149 stocks in both. VHT costs 0.09% a year against 0.44% for IBB, $35 a year less on $10,000. Over the last twelve months IBB returned +50.6% and VHT +16.7%.

17%of the two portfolios is the same stocks at the same weight
IBB84% in stocks the other holds too
VHT17% in stocks the other holds too
stocks in bothstocks only in that fundbonds, cash and unmatched shares

The two funds

From each fund's latest N-PORT filing and its prospectus.

IBBVHTYearly cost0.44%0.09%Net assets$9.1B$19.0BPositions252407Last 12 months+50.6%+16.7%3 years, a year+14.7%+7.5%5 years, a year+3.3%+4.6%Largest holdingBlackRock 12.0%LLY 14.0%Main sectorHealthcare 97%Healthcare 99%Holdings as ofJun 30, 2026May 31, 2026

Returns are total returns with dividends reinvested, from the funds’ own monthly figures; “(price)” marks a fund whose filing record is younger than a year, whose twelve months are its price change. The stronger figure in each row is set in bold. Past returns say what happened, not what will.

Growth of $100

Both funds from September 2019, the first month both report, dividends reinvested.

IBB$170VHT$182
September 2019May 2026

More comparisons

From each fund’s Form N-PORT (IBB: June 2026, VHT: May 2026) and prospectus, via the SEC’s public data sets. Overlap counts only the stocks we can match to a listing: stock by stock, the smaller of the two weights, added up.